News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.
FDA warns drugmakers in India, China, France and Malaysia over GMP violations
The U.S. Food and Drug Administration (FDA) has sent six warning letters to drug manufacturing firms in India, China, France, and Malaysia for severe violations of Good Manufacturing Practices (GMP).
May 14, 2025
ICMR to launch landmark clinical trial on high-dose Rifampicin for TB treatment
The Indian Council of Medical Research–National Institute for Research in Tuberculosis (ICMR-NIRT) has announced a forthcoming multi-centric clinical trial to test high-dose rifampicin-based regimens for drug-sensitive pulmonary tuberculosis (TB).
May 13, 2025
Steroid misuse and protein powders linked to hip damage in indian youth
Top orthopaedic surgeons have sounded warning bells about the increasing abuse of anabolic steroids and unregulated protein supplements among youth gym enthusiasts in India.
May 13, 2025
Telangana DCA seizes ₹1.73 crore worth spurious drugs and issues public advisory on QR code verification
The Telangana Drugs Control Administration (DCA) has intensified its crackdown on counterfeit drug rackets with seizures worth ₹1.73 crore since December 2023.
May 13, 2025
Trump to sign executive order linking US drug prices to global rates
Former U.S. President Donald Trump has stated he plans to sign an executive order that would align American prescription drug prices with the lowest paid by high-income nations.
May 12, 2025
Expired medicines recovered from Quack's clinic in Sangareddy
During a crackdown on illegal medical practices, Telangana Drugs Control Administration (DCA) seized expired and unlicensed medicines valued at ₹10,000 from an unqualified practitioner running a clinic in Sangareddy district.
May 11, 2025
BCDA Reports 47% Surge in Spurious Medicines Post-COVID
A 47% increase in spurious and substandard drugs since the Covid-19 pandemic has been reported by the Bengal Chemists and Druggists Association (BCDA). The Central Drugs Standard Control Organisation (CDSCO) also noted January 2025 as one of the highest recorded detection periods of non-standard quality (NSQ) drugs in recent history. As per BCDA, the competition on the basis of discounts in the pharma industry and the introduction of GST have been the factors that have increased the number of spurious drugs. The body alerted consumers and authorities to the possible health consequences of using unauthorized sources of drugs.
Mar 8, 2025
India's Bulk Drug Imports Rise 2.3% during Nine Months of FY25
India's imports of bulk drugs and drug intermediates registered a 2.34% growth during the first nine months of FY25 to $3.5 billion from $3.42 billion during the corresponding period of FY24. The December 2024 quarter witnessed a marginal growth of 1.6%, with imports at $1.21 billion from $1.19 billion in the same quarter last year, as per Ministry of Commerce and Industry data.
Mar 8, 2025
Dangerous Counterfeit Drugs Flooding Markets: Major Gang Busted in Delhi
Delhi Police's Crime Branch on Monday dismantled a vast nationwide fake medicine network by arresting 10 people who were making, selling, and distributing spurious drugs across states. The raids resulted in two manufacturing units being sealed in Ghaziabad and Shamli while unearthing fake drugs worth crores.
Mar 8, 2024
India and Belgium Join Hands to Enhance RNA-Based Vaccine Development
TechInvention Lifecare Pvt. Ltd. has formed a strategic alliance with Quantoom Biosciences, Belgium, to promote RNA-based vaccine development in India. The Memorandum of Understanding (MoU) was signed during the Belgian Economic Mission to India, in the presence of Her Royal Highness Princess Astrid of Belgium, industry leaders, and key stakeholders from both countries. This partnership is intended to enhance India's biotech industry through the introduction of innovative RNA production solutions, with an emphasis on affordability, scalability, and accessibility.
Mar 7, 2025
AstraZeneca Gets Nod to Import and Market Hyperkalaemia Treatment Drug in India
AstraZeneca Pharma India Ltd has been granted regulatory approval by the Central Drugs Standard Control Organisation (CDSCO) to import and sell sodium zirconium cyclosilicate powder for oral suspension (Lokelma) in India. The drug is prescribed for the treatment of hyperkalaemia, a condition that is defined by high levels of potassium in the blood.
Mar 6, 2025
Gurugram Authorities Arrest Man for Selling Counterfeit Medicines and Steroids
In a major crackdown on illicit drug supply, the Drugs Control Department in Gurugram arrested a 22-year-old man for selling spurious medicines and steroids without a valid drug license. The drive was aimed at unauthorized growth hormones, anabolic steroids, and expired drugs being supplied to gym enthusiasts and bodybuilders.
Mar 5, 2025
ICMR Releases Ethical Guidelines for Integrative Medicine Research to Enhance Ayush-Based Healthcare
The Indian Council of Medical Research (ICMR) has released an addendum to its National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017), which offers a systematic ethical framework for Research in Integrative Medicine (RIM). The move is expected to enhance credibility and confidence in scientific research that combines Ayush-based and conventional medicine.
Mar 5, 2025
Global Generic Drug Market to Reach $681.57 Billion by 2032 Amid Rising Demand for Affordable Medications
The worldwide generic drug market is anticipated to expand at a CAGR of 5.22% from 2025 to 2032, reaching a value of $681.57 billion. The surge in growth is driven by increasing healthcare expenses, patent loss of branded medications, and government regulations supporting cost-saving treatment plans.
Mar 4, 2025
Noida Court Upholds Copyright Protection for Jubilant's Pharmaceutical Dossiers Against Indian Manufacturers
The Noida Commercial Court has maintained an injunction against four Indian pharma companies for illegally producing and exporting pharmaceuticals based on Jubilant Generics Limited's proprietary information. The decision strengthens copyright protection for Jubilant's confidential product dossiers, preventing unauthorized use, production, and exports.
Mar 4, 2025
SCDA Urges NPPA to Withdraw Office Memorandum on E-Pharmacies and Publish Price List Online
South Chemists & Distributors Association (SCDA) has sharply criticized the National Pharmaceutical Pricing Authority (NPPA) for recognizing e-pharmacies in its recent Office Memorandum (OM). SCDA claims that e-pharmacies are unregulated and thus illegal under the Drugs & Cosmetics Act. SCDA has also requested NPPA to provide public access to the price list of medicine on the internet, instead of insisting on physical display in pharmacies.
Mar 4, 2025
Wipro GE Healthcare Launches AI-Powered 'Made in India' Ultrasound System Versana Premier R3
Wipro GE Healthcare Pvt Ltd, a top global healthcare technology provider, has introduced Versana Premier R3, a cutting-edge AI-powered ultrasound system that aims to improve clinical efficiency, simplify workflows, and enhance diagnostic accuracy. The new system will be produced at Wipro GE Healthcare's PLI factory in Bengaluru, promoting India's 'Make in India' initiative.
Mar 4, 2025
Long-Term Antidepressant Use May Increase Risk of Sudden Cardiac Death
A new study presented at the European Society of Cardiology's EHRA 2025 Congress has raised serious concerns about the long-term use of antidepressants (ADs).
Mar 31, 2025
Massive Crackdown in Gujarat: 50 Lakh Bottles of Codeine Seized in Statewide Raids
In a large-scale crackdown on the illegal sale of prescription drugs, Gujarat authorities have seized over 50 lakh bottles of codeine-based syrups from chemist shops across the state.
Mar 30, 2025
RMSCL to use automated demand system to tackle drug shortages in govt hospitals
To resolve recurring shortages of essential medicines under Rajasthan’s free medicine scheme, the Rajasthan Medical Services Corporation Limited (RMSCL) is rolling out an automated drug demand generation system across government hospitals.
Mar 30, 2025
AstraZeneca Pharma India Gets CDSCO Approval to Import and Sell Cancer Treatment Medicine
AstraZeneca Pharma India Ltd. has received import and distribution licensing from the Central Drugs Standard Control Organisation (CDSCO) to market its anti-cancer therapy drug, Durvalumab (Imfinzi), in India. With this approval, the company will be able to market Durvalumab solution for infusion 120 mg/2.4 ml and 500 mg/10 ml to treat patients suffering from unresectable hepatocellular carcinoma (uHCC).
Mar 3, 2025
CAG Report Reveals 15 Lakh Units of Substandard Medicines Given to Patients in Delhi Hospitals
A shocking revelation by the Comptroller and Auditor General of India (CAG) has exposed serious lapses in Delhi’s public healthcare system. The report reveals that 15 lakh units of substandard medicines were administered to patients in government hospitals between 2015 and 2022, posing significant health risks.
Mar 3, 2025
Philips and Medtronic Join Forces to Train Over 300 Clinicians in Structural Heart Imaging in India
Philips and Medtronic have entered into a Memorandum of Understanding (MoU) in India, which is a strategic initiative to boost medical skills in structural heart imaging. The partnership will see more than 300 cardiologists and radiologists trained on cutting-edge imaging methods, specifically for treating patients with end-stage renal disease (ESRD).
Mar 3, 2025
Cardiac Stents to Cost 2% More as NPPA Allows Price Revision
The National Pharmaceutical Pricing Authority (NPPA) approved a 1.74% hike in price for coronary stents, following which the costs of treatment in heart patients might go up by a certain margin in India.
Mar 29, 2025
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.